Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria.
Ferrer M, Boccon-Gibod I, Gonçalo M, İnalöz HS, Knulst A, Lapeere H, Parthasaradhi A, Stingl G, Tagka A, Valenzuela F, Yeung J, Thomsen SF.
Ferrer M, et al. Among authors: thomsen sf.
Eur J Dermatol. 2017 Oct 1;27(5):455-463. doi: 10.1684/ejd.2017.3085.
Eur J Dermatol. 2017.
PMID: 29084635